Latest news ...

Some of our recent news articles.

 
08
August
2019
08th August 2019
 

GSK raises 2019 earnings expectations after standout quarter for Shingrix

Sales of shingles vaccine more than doubles, beating market projections

 
Read the full story »
 
 
10
April
2019
10th April 2019
 

Pharma GSK's Dovato chalks up first 2-drug regimen nod for new HIV patients.

Approval based on GEMINI pivotal trials in which Dovato achieved non-inferior efficacy compared to a dolutegravir-based, traditional, three-drug regimen through 48 weeks, with no cases of resistance.[1]

 
Read the full story »
 
 
08
January
2019
08th January 2019
 

Drugmaker GSK plans split after consumer health tie-up with Pfizer

New consumer health joint venture will have market share well above rivals, at 7.3%

 
Read the full story »
 
 
19
December
2018
19th December 2018
 

Drugmaker GSK to split after folding in Pfizer consumer unit

 New consumer health joint venture with Pfizer to be 68% owned by GSK

 
Read the full story »
 
 
06
December
2018
06th December 2018
 

GlaxoSmithKline selling Horlicks and buying Tesaro

The company is investing further in pharma

 
Read the full story »
 
 
23
March
2018
23rd March 2018
 

GSK pulls out of $20bn race for Pfizer consumer assets

Second withdrawal leaves Pfizer with limited options in offloading portfolio
 
Read the full story »
 
 
20
July
2017
20th July 2017
 

GSK says UK manufacturing cuts not Brexit related

GSK has announced a shakeup of its UK network, shelving plans for Ulverston biopharma plant, mooting the sale of its cephalosporin antibiotics business and pledging to invest in HIV and respiratory drug capacity.
 
Read the full story »
 
 
27
April
2017
27th April 2017
 

GlaxoSmithKline posts 31% gain in first-quarter profit

Weaker pound and rising sales assist pharma giant as asthma drug demand falters
 
Read the full story »
 
 
28
February
2017
28th February 2017
 

GSK closing Costa Rica consumer products plant, cutting 62 jobs

GlaxoSmithKline is giving up on manufacturing in Costa Rica and will wind down operations at its consumer health products plant in San Jose over the next three years. The move will cost more than 60 people their jobs.
 
Read the full story »
 
 
13
February
2017
13th February 2017
 

How much Advair pain does GSK expect? Its 2017 forecast lays out the numbers

GlaxoSmithKline’s Andrew Witty has spent his entire CEO stint fending off concerns about the arrival of generic Advair. But on his final quarterly conference call as helmsman, he finally laid out just how much damage the company expects a knockoff can do.
 
Read the full story »
 
 
08
August
2016
08th August 2016
 

Glaxo and Alphabet in venture to develop bioelectronic drugs

UK pharma group and Google parent to invest up to €640 million over seven years
 
Read the full story »
 
 
18
May
2016
18th May 2016
 

Glaxo's Bexsero supply rebounds after demand for MenB jab outstrips supply

Good news for GlaxoSmithKline, and those U.K. parents wanting to get their hands on its meningitis B vaccine, Bexsero: The wait is over.

Glaxo will have a global shortage resolved by next month, it told The Guardian, with new stocks of the jab already on their way to private clinics in its home country.
 
Read the full story »
 
 
01
April
2016
01st April 2016
 

GlaxoSmithKline to 'drop patents in poor countries for better drug access'

Pharmaceutical firm GlaxoSmithKline has said it wants to make it easier for manufacturers in the world's poorest countries to copy its medicines.
 
Read the full story »
 
 
04
February
2016
04th February 2016
 

GSK chief asks for three years for profit increase

Andrew Witty tells investors he will improve profitability at Glaxo’s consumer unit
 
Read the full story »
 
 
28
October
2015
28th October 2015
 

Glaxo Smith Kline profits fall despite better-than-expected earnings

GlaxoSmithKline, the UK’s biggest drugmaker, reported third-quarter earnings that surpassed analysts’ estimates as sales of HIV drugs, vaccines and consumer health-care products climbed.
Profit excluding certain costs dropped 5 per cent to £1.72 billion (€2.37 billion), the London-based company said in a statement.
 
Read the full story »
 
 
04
August
2015
04th August 2015
 

GSK sinks Advair prices to fend off Cipla copycat in India

The pharma giant has halved the prices for the respiratory behemoth in the country to match that of Cipla's knockoff, Sereflo. And others may alter their prices accordingly, The Economic Times reports.
 
Read the full story »
 
 
29
July
2015
29th July 2015
 

GlaxoSmithKline beats profit forecasts despite Advair hit and lower margins

CEO Witty focuses on depth of research pipeline which features around 40 potential new drugs and vaccines
 
Read the full story »
 
 
08
April
2015
08th April 2015
 

GSK agrees UK deal for meningitis shot after Novartis stand-off

Reuters) - GlaxoSmithKline has reached a deal with the British government to supply a new meningitis B vaccine, following a lengthy stand-off over price with the product's previous owner Novartis.
 
Read the full story »
 
 
 
 
 
 
 
 
 

About Us

SURIMS is the new name for Actex Pharma Services which was a consultancy established in 2003, supporting companies in the identification, qualification and management of quality vendors and suppliers in ingredients and formulations.

The Pharmaceutical Services Directory supports the identification and on-boarding of quality suppliers and also incorporates software features that manage relationships between suppliers and their customers. These include the building and deployment of questionnaires and assessments, electronic signatures and sign-offs and project management between vendor/partner and customer.

Access to the features and software is available on a 'pay as you go' basis, or a customised version can be licensed for your company for its own supplier on-boarding and supplier management activities. Further information on our software services please contact Tel: +353 87 294 0436 or email info@pharmaservicesdirectory.com

 
 
 

Get in Touch

The Pharmaceutical Services Directory
info@pharmaservicesdirectory.com.

 
 

© 2019 Actex Pharma Services | All Rights Reserved.